PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CANC vs. IYH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CANC and IYH is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

CANC vs. IYH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Oncology ETF (CANC) and iShares U.S. Healthcare ETF (IYH). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%SeptemberOctoberNovemberDecember2025February
-9.45%
-3.87%
CANC
IYH

Key characteristics

Sharpe Ratio

CANC:

-0.25

IYH:

0.27

Sortino Ratio

CANC:

-0.21

IYH:

0.46

Omega Ratio

CANC:

0.98

IYH:

1.05

Calmar Ratio

CANC:

-0.29

IYH:

0.25

Martin Ratio

CANC:

-0.60

IYH:

0.64

Ulcer Index

CANC:

8.28%

IYH:

4.90%

Daily Std Dev

CANC:

19.84%

IYH:

11.52%

Max Drawdown

CANC:

-16.81%

IYH:

-43.12%

Current Drawdown

CANC:

-13.26%

IYH:

-6.55%

Returns By Period

In the year-to-date period, CANC achieves a 4.04% return, which is significantly lower than IYH's 5.71% return.


CANC

YTD

4.04%

1M

4.16%

6M

-9.42%

1Y

-4.17%

5Y*

N/A

10Y*

N/A

IYH

YTD

5.71%

1M

3.93%

6M

-3.75%

1Y

3.11%

5Y*

8.20%

10Y*

8.97%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CANC vs. IYH - Expense Ratio Comparison

CANC has a 0.75% expense ratio, which is higher than IYH's 0.43% expense ratio.


CANC
Tema Oncology ETF
Expense ratio chart for CANC: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for IYH: current value at 0.43% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.43%

Risk-Adjusted Performance

CANC vs. IYH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CANC
The Risk-Adjusted Performance Rank of CANC is 44
Overall Rank
The Sharpe Ratio Rank of CANC is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of CANC is 55
Sortino Ratio Rank
The Omega Ratio Rank of CANC is 55
Omega Ratio Rank
The Calmar Ratio Rank of CANC is 22
Calmar Ratio Rank
The Martin Ratio Rank of CANC is 44
Martin Ratio Rank

IYH
The Risk-Adjusted Performance Rank of IYH is 1212
Overall Rank
The Sharpe Ratio Rank of IYH is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of IYH is 1111
Sortino Ratio Rank
The Omega Ratio Rank of IYH is 1111
Omega Ratio Rank
The Calmar Ratio Rank of IYH is 1515
Calmar Ratio Rank
The Martin Ratio Rank of IYH is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CANC vs. IYH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Oncology ETF (CANC) and iShares U.S. Healthcare ETF (IYH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CANC, currently valued at -0.25, compared to the broader market0.002.004.00-0.250.27
The chart of Sortino ratio for CANC, currently valued at -0.21, compared to the broader market-2.000.002.004.006.008.0010.0012.00-0.210.46
The chart of Omega ratio for CANC, currently valued at 0.98, compared to the broader market0.501.001.502.002.503.000.981.05
The chart of Calmar ratio for CANC, currently valued at -0.29, compared to the broader market0.005.0010.0015.00-0.290.25
The chart of Martin ratio for CANC, currently valued at -0.60, compared to the broader market0.0020.0040.0060.0080.00100.00-0.600.64
CANC
IYH

The current CANC Sharpe Ratio is -0.25, which is lower than the IYH Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of CANC and IYH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
-0.25
0.27
CANC
IYH

Dividends

CANC vs. IYH - Dividend Comparison

CANC's dividend yield for the trailing twelve months is around 2.88%, more than IYH's 1.18% yield.


TTM20242023202220212020201920182017201620152014
CANC
Tema Oncology ETF
2.88%2.99%0.56%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IYH
iShares U.S. Healthcare ETF
1.18%1.25%1.18%1.10%0.94%1.16%1.14%1.95%1.10%1.29%2.02%1.05%

Drawdowns

CANC vs. IYH - Drawdown Comparison

The maximum CANC drawdown since its inception was -16.81%, smaller than the maximum IYH drawdown of -43.12%. Use the drawdown chart below to compare losses from any high point for CANC and IYH. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-13.26%
-6.55%
CANC
IYH

Volatility

CANC vs. IYH - Volatility Comparison

Tema Oncology ETF (CANC) has a higher volatility of 6.40% compared to iShares U.S. Healthcare ETF (IYH) at 3.87%. This indicates that CANC's price experiences larger fluctuations and is considered to be riskier than IYH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%SeptemberOctoberNovemberDecember2025February
6.40%
3.87%
CANC
IYH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab